🇺🇸 FDA
Patent

US 12251449

Synthetic multidomain peptide biomaterials that inhibit inducible nitric oxide synthase

granted A61KA61K2039/507A61K31/7052

Quick answer

US patent 12251449 (Synthetic multidomain peptide biomaterials that inhibit inducible nitric oxide synthase) held by The Board of Regents of the University of Texas System expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/507, A61K31/7052, A61K47/6903, A61K9/0019